[Contribution to the treatment of xanthomatoses].
D002087:Butyrates / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D008297:Male; D014280:Triglycerides / Q000037:antagonists & inhibitors* / Q000097:blood; D014973:Xanthomatosis / Q000188:drug therapy*
D002087:Butyrates; D000960:Hypolipidemic Agents; D008055:Lipids; D008074:Lipoproteins; D014280:Triglycerides
Beitrag zur Behandlung der Xanthomatosen.